Literature DB >> 17070579

Report of two cases of ciliary body mesectodermal leiomyoma: unique expression of neural markers.

Alexandre N Odashiro1, Bruno F Fernandes, Abdullah Al-Kandari, Francois J Gregoire, Miguel N Burnier.   

Abstract

OBJECTIVE: Mesectodermal leiomyoma of the ciliary body is a rare tumor with, to our knowledge, only 15 cases reported in the literature. It has a neural histopathologic appearance and a presumed origin from neural crest.
DESIGN: Case report.
RESULTS: Two cases of mesectodermal leiomyoma with histopathologic and immunohistochemical confirmation are reported.
CONCLUSIONS: For the second time, we were able to demonstrate expression of neural immunohistochemical markers in this tumor.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17070579     DOI: 10.1016/j.ophtha.2006.07.023

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

1.  Ciliary Body Leiomyoma.

Authors:  Paulina Plesníková; Denisa Jurenová; Darina Lysková; Alena Furdová; Jela Valášková; Pavel Babál
Journal:  Case Rep Ophthalmol       Date:  2022-04-05

2.  Ciliary Body Mesectodermal Leiomyoma Diagnosed by Fine Needle Aspiration Biopsy.

Authors:  Hayyam Kiratli; Abdullah Ağın; Sevgen Önder
Journal:  Ocul Oncol Pathol       Date:  2017-02-15

3.  Aqueous immune mediators in malignant uveal melanomas in comparison to benign pigmented intraocular tumors.

Authors:  Yoshihiko Usui; Kinya Tsubota; Tsuyoshi Agawa; Shunichiro Ueda; Kazuhiko Umazume; Yoko Okunuki; Takeshi Kezuka; Naoyuki Yamakawa; Hiroshi Goto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-11-22       Impact factor: 3.117

4.  Pathology features and the results of treatment of two cases of posterior choroidal leiomyoma.

Authors:  Nan Zhou; Wenbin Wei; Xiaolin Xu
Journal:  BMC Ophthalmol       Date:  2020-05-24       Impact factor: 2.209

5.  Acute Presentation of Mesectodermal Leiomyoma of the Ciliary Body.

Authors:  Jenna May Kim; Laura Bressler Hall; Maxwell Elia; Michael S Ehrlich; Miguel A Materin; John H Sinard
Journal:  Ocul Oncol Pathol       Date:  2017-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.